The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis

Annals of the Rheumatic Diseases

Volumn 69, Issue 3, 2010, Pages 495-502

  Machold, Klaus P ^a   Landewé, Robert ^b   Smolen, Josef S ^a   Stamm, Tanja A ^a   Van Der Heijde, Désirée M ^c   Verpoort, Kirsten N ^c   Brickmann, Kerstin ^d   Vázquez Mellado, Janitzia ^e   Karateev, Dimitri E ^f   Breedveld, Ferdinand C ^c   Emery, Paul ^g   Huizinga, Thomas W J ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^f V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

^g Academic Unit of Musculoskeletal Disease   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHYLPREDNISOLONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTHRITIS; ARTICLE; CARPAL TUNNEL SYNDROME; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OSTEOARTHRITIS; POLYARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS; DRUG THERAPY, COMBINATION; EPIDEMIOLOGIC METHODS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; REMISSION INDUCTION; YOUNG ADULT;

EID: 77949438480     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.122473     Document Type: Article

References (56)

1. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008;26(5 Suppl 51):S35-61.
2. Masi AT. Articular patterns in the early course of rheumatoid arthritis. Am J Med 1983;75:16-26.
3. Emery P, Breedveld FC, Dougados M, et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61:290-7.
4. Huizinga TW, Machold KP, Breedveld FC, et al. Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis. Arthritis Rheum 2002;46:1155-9.
5. Aletaha D, Breedveld FC, Smolen JS. The need for new classification criteria for rheumatoid arthritis. Arthritis Rheum 2005;52:3333-6.
6. van der Heide A, Jacobs JW, Bijlsma JW, et al. The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996;124:699-707.
7. Albers JM, Paimela L, Kurki P, et al. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:453-8.
8. Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51.
9. Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 2003;21(5 Suppl 31):S154-7.
10. Combe B. Should patients with recent-onset polyarthritis receive aggressive treatment? Joint Bone Spine 2004;71:475-80.
11. Raza K, Buckley CE, Salmon M, et al. Treating very early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2006;20:849- 63.
12. Hanissian AS, Robinson H, Masi AT, et al. Proceedings: comparison of early patterns of rheumatoid arthritis (RA) in juveniles and young adults: data supporting a unified disease concept. Arthritis Rheum 1975;18:527.
13. Feigenbaum SL, Masi AT, Kaplan SB. Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients. Am J Med 1979;66:377-84.
14. Eberhardt KB, Rydgren LC, Pettersson H, et al. Early rheumatoid arthritis - onset, course, and outcome over 2 years. Rheumatol Int 1990;10:135-42.
15. Green M, Marzo-Ortega H, McGonagle D, et al. Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis Rheum 1999;42:2184-8.
16. El-Gabalawy HS, Goldbach-Mansky R, Smith D 2nd, et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 1999;42:1696-705.
17. Young A, Dixey J, Cox N, et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford) 2000;39:603-11.
18. Symmons DP, Silman AJ. The Norfolk Arthritis Register (NOAR). Clin Exp Rheumatol 2003;21(5 Suppl 31):S94-9.
19. Bridges SL Jr, Hughes LB, Mikuls TR, et al. Early rheumatoid arthritis in African-Americans: the CLEAR Registry. Clin Exp Rheumatol 2003;21(5 Suppl 31):S138-45.
20. Sokka T. Early rheumatoid arthritis in Finland. Clin Exp Rheumatol 2003;21(5 Suppl 31):S133-7.
21. Ferraccioli GF. Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteria. Clin Exp Rheumatol 2003, 21:S129-S132.
22. Combe B. The French early arthritis registry. Clin Exp Rheumatol 2003;21(5 Suppl 31):S123-8.
23. Kvien TK, Uhlig T. The Oslo experience with arthritis registries. Clin Exp Rheumatol 2003;21(5 Suppl 31):S118-22.
24. Zeidler H, Merkesdal S, Hülsemann JL. Early arthritis and rheumatoid arthritis in Germany. Clin Exp Rheumatol 2003;21(5 Suppl 31):S106-12.
25. van Aken J, van Bilsen JH, Allaart CF, et al. The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003;21(5 Suppl 31):S100-5.
26. Machold KP, Nell VP, Stamm TA, et al. The Austrian Early Arthritis Registry. Clin Exp Rheumatol 2003;21(5 Suppl 31):S113-17.
27. Machold KP, Eberl G, Leeb BF, et al. Early arthritis therapy: rationale and current approach. J Rheumatol Suppl 1998;53:13-19.
28. van der Horst-Bruinsma IE, Speyer I, Visser H, et al. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 1998;37:1084-8.
29. Möttönen T, Hannonen P, Leirisalo-Repo M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999;353:1568-73.
30. Nell VP, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004;43:906-14.
31. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-93.
32. St Clair EW, van der Heijde DM, Smolen JS, et al.; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004;50:3432-43.
33. Landewé RB, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
34. Goekoop-Ruiterman YPM, Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study) - A randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
35. Harrison BJ, Symmons DP, Brennan P, et al. Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol 1996;35:1096-100.
36. Tunn EJ, Bacon PA. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 1993;32:97-103.
37. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 1995;333:142-6.
38. van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, et al. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.
39. Kirwan JR, Bijlsma JW, Boers M, et al. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev 2007:CD006356.
40. Boers M. The case for corticosteroids in the treatment of early rheumatoid arthritis. Rheumatology (Oxford) 1999;38:95-7.
41. Neeck G. Fifty years of experience with cortisone therapy in the study and treatment of rheumatoid arthritis. Ann NY Acad Sci 2002;966:28-38.
42. Quinn MA, Green MJ, Marzo-Ortega H, et al. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 2003;48:3039-45.
43. Hernández-García C, Vargas E, Abásolo L, et al. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 2000;27:2323-8.
44. Cush JJ. Early arthritis clinic: a USA perspective. Clin Exp Rheumatol 2003;21(5 Suppl 31):S75-8.
45. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729-40.
46. Smolen JS. Report of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials. Rheumatol Eur 1994, 23:37-39.
47. The EULAR Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). EULAR handbook of clinical assessments in rheumatoid arthritis, 4th edn. van Riel PLCM, Scott DL, eds. Alphen aan den Rijn: Van Zuiden Communications BV, 2004.
48. Boers M, Tugwell P, Felson DT, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl 1994;41:86-9.
49. Felson DT. Choosing a core set of disease activity measures for rheumatoid arthritis clinical trials. J Rheumatol 1993;20:531-4.
50. Visser H, le Cessie S, Vos K, et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002;46:357-65.
51. Schumacher HR. Early arthritis clinics. Much early arthritis is unclassified. J Rheumatol 2002;29:2258-60.
52. Machold KP, Stamm TA, Eberl GJ, et al. Very recent onset arthritis - clinical, laboratory, and radiological findings during the first year of disease. J Rheumatol 2002;29:2278-87.
53. Pincus T. Limitations of randomized controlled clinical trials to depict accurately longterm outcomes in rheumatoid arthritis. Z Rheumatol 1998;57:46-9.
54. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263- 9.
55. Verstappen SM, McCoy MJ, Roberts C, et al. The beneficial effects of a 3 week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: Results of the STIVEA trial. Ann Rheum Dis 2010;69:503-9.
56. Bos WH, Wolbink GJ, Boers M, et al. Arthritis development in arthralgia patients is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 2010;69:490-4.